Swiss contract drug manufacturer PolyPeptide is attracting takeover interest from private equity firms including EQT and KKR, Bloomberg News reports, citing sources familiar with the matter. Advent is also reportedly evaluating a potential deal, and any prospective buyer may seek to partner with majority shareholder Frederik Paulsen.
The company, which develops and manufactures synthetic peptides for treatments including obesity and diabetes, is valued at approximately 1 billion Swiss francs following a share price increase of nearly 20 percent this year.
While discussions are ongoing, no deal is guaranteed, according to the sources.
KKR & Co. Inc. is a financial services group organized around 2 areas of activity:
- insurance (67% of revenues): notably life insurance and pensions. The group also offers reinsurance solutions for private and institutional clients;
- asset management (33%): management of private equity funds, equity funds, alternative credits, real estate assets, energy and infrastructure assets, investment funds, etc. In 2024, KKR & Co. Inc. has USD 637,572 million of assets under management.
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
